Advanced Nonhematological Neoplasms
1 clinical trials · Condition
◉ Watch Advanced Nonhematological Neoplasms
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of TAK-228 as Single Agent in Adult East Asian Participants With Advanced Nonhematological Malignancies (NCT03370302) | Calithera Biosciences, Inc | 2018-01-17 |
Track Advanced Nonhematological Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.